NEWS: 公告在東京證券交易所JASDAQ標準市場新上市


支架市場 - 成長,趨勢,預測

Stents Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 922036
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
支架市場 - 成長,趨勢,預測 Stents Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 112 Pages

本報告提供支架的世界市場調查,提供市場概要,各類型,各地區的市場趨勢,市場規模的變化與預測,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊 。


第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品
    • 冠狀動脈支架
    • 週邊支架
    • 支架植入
  • 不同材料
    • 金屬生物材料
    • 高分子生物材料
    • 天然生物材料
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Boston Scientific
    • Abbott
    • Medtronic
    • B. Braun Melsungen AG
    • CR Bard, Inc.
    • Microport Scientific Corporation
    • Stentys SA
    • Biotronik SE & Co. KG
    • Cook Medical Technologies
    • Terumo Corporation

第7章 市場機會及未來趨勢


Product Code: 67149

The major factors found propelling the growth of the stents market include the increasing prevalence of chronic illnesses like cardiovascular diseases, rising the geriatric population, and the technological advancements in stents.

The prevalence of chronic illnesses has been increasing in the recent decades. Coronary Vascular Diseases (CVD) were the number one cause of death globally as per World Health Organisation 2017. An estimated 17.9 million people died from CVDs in 2016, which represents 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke. Hence as stents are used in surgeries, the market is expected to grow with such high prevalence.

There has also been a high demand for minimally invasive surgical procedures that is likely to significantly drive the stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized stents.

Key Market Trends

Coronary Stents are expected to cover a large share of stents global market

A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in the treatment of coronary heart disease. In the recent times, usage of coronary stent in surgical procedures has increased due to increase in cardiovascular disease. According to American Heart Association, the global deaths due to cardiovascular disease was 17.6 million in 2016 and is expected to rise to 23.6 million in 2030.

With rise in number of deaths due to cardiovascular disease, the demand for surgery involving coronary stents is expected to increase, helping the stents market grow.

North America is expected to dominate the market

According center for American Heart Association, cardiovascular disease (CVD), which was listed as the leading cause of death, accounted for more than 800,000 deaths in the US in 2016, which represents approximately 1 of every 3 deaths. Between 2013 and 2016, 121.5 million American adults had some form of cardiovascular disease. Coronary Heart Disease was the leading cause (43.2%) of deaths attributable to cardiovascular disease, followed by stroke (16.9%).

However, as United States has a developed healthcare system structure, it invests a lot in awareness and treatments. According to American Heart Association, between 2014 and 2015, direct and indirect costs of total cardiovascular diseases and stroke were USD 351.2 billion.

Owing to aforemention factors, the United States stents market is expected to increase in the forecast period.

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. The competition is fierce due to the consolidated nature of the market with top three players reporting to occupy major share in the market. The key players in the stents market are adopting various strategic moves to sustain the intense competition.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Diseases
    • 4.2.2 Increasing Geriatric Population
    • 4.2.3 Technological Advancements in Stent Development
  • 4.3 Market Restraints
    • 4.3.1 Stringent Approval Process for Stents
    • 4.3.2 High Product Recalls
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product
    • 5.1.1 Coronary stents
      • Drug-eluting stents
      • Bare-metal coronary stents
      • Bioabsorbable stents
    • 5.1.2 Peripheral stents
      • Iliac stents
      • Femoral-popliteal stents
      • Renal & related stents
      • Carotid stents
    • 5.1.3 Stent Implants
  • 5.2 By Material
    • 5.2.1 Metallic biomaterials
    • 5.2.2 Polymeric biomaterials
    • 5.2.3 Natural biomaterials
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Boston Scientific Corporation
    • 6.1.2 Abbott Laboratories
    • 6.1.3 Medtronic PLC
    • 6.1.4 B. Braun Melsungen AG
    • 6.1.5 Becton, Dickinson and Company
    • 6.1.6 Microport Scientific Corporation
    • 6.1.7 Stentys S.A.
    • 6.1.8 Biotronik SE & Co. KG
    • 6.1.9 Cook Group
    • 6.1.10 Terumo Corporation